KT-MED

Critical Care Range

KT-MED

Ketorolac Tromethamine Injection

Composition (Each ml contains):

  • Ketorolac Tromethamine: 30 mg

Dosage Form: Injection

Therapeutic Class: Non-Steroidal Anti-Inflammatory Drug (NSAID) – Analgesic

KT-MED is a potent injectable analgesic formulated with Ketorolac Tromethamine 30 mg per ml for short-term management of moderate to severe acute pain. It belongs to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class and works by inhibiting prostaglandin synthesis responsible for pain and inflammation. The injection offers rapid pain relief without causing sedation, making it suitable for post-operative and trauma-related pain control. KT-MED is commonly administered in hospital and emergency care settings where fast, effective analgesia is required under medical supervision.

MRP: ₹42

Uses

KT-MED is a potent injectable analgesic formulated with Ketorolac Tromethamine 30 mg per ml for short-term management of moderate to severe acute pain. It belongs to the Non-Steroidal Anti-Inflammatory Drug (NSAID) class and works by inhibiting prostaglandin synthesis responsible for pain and inflammation. The injection offers rapid pain relief without causing sedation, making it suitable for post-operative and trauma-related pain control. KT-MED is commonly administered in hospital and emergency care settings where fast, effective analgesia is required under medical supervision.

Side Effects

  • Gastrointestinal irritation or pain
  • Headache or dizziness
  • Nausea or vomiting
  • Injection site pain or inflammation
  • Increased risk of bleeding
  • Renal function impairment with prolonged use
  • Elevated liver enzymes

Indications

  • Management of moderate to severe acute pain
  • Post-operative pain relief
  • Pain associated with musculoskeletal injuries
  • Renal colic-related pain
  • Pain management where opioid-sparing therapy is preferred

FAQ

Q: Why do healthcare professionals often choose Ketorolac over opioid analgesics to treat acute pain?

A: It provides strong pain relief without sedation or risk of dependence associated with opioids, which makes it ideal to use in acute pain.

Q: Is it safe to use KT-MED injection for long-term pain management under medical supervision?

A: No, KT-MED is intended for short-term use only, as it may cause gastrointestinal and renal risks.

Q: How much time does Ketorolac injection take to start relieving pain?

A: After administration, it generally begins within 30 minutes to offer pain relief.

Q: Does taking KT-MED affect platelet function?

A: It may temporarily inhibit platelet aggregation, which can increase bleeding risk in certain patients.

Q: Can an elderly patient take this injection? Does it work appropriately?

A: Yes, it can be used cautiously under medical supervision, as it may require dose adjustment and close monitoring.

Q: Do healthcare professionals prescribe this injection combined with paracetamol or other analgesics?

A: It can be used as a combination therapy to enhance pain control under medical guidance.

Q: Does it require kidney function monitoring during Ketorolac therapy?

A: It is recommended to monitor renal function, especially in high-risk patients.

Indications

  • Management of moderate to severe acute pain
  • Post-operative pain relief
  • Pain associated with musculoskeletal injuries
  • Renal colic-related pain
  • Pain management where opioid-sparing therapy is preferred

FAQ

Apply for PCD Franchise – Not for Job Queries

Do You Have Drug License?

Apply for PCD Franchise – Not for Job Queries